The journey from the old to the new AMH assay: how to avoid getting lost in the values

Al-Qahtani, 2005, Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females, Clin. Endocrinol. (Oxf), 63, 267, 10.1111/j.1365-2265.2005.02336.x Anderson, 2006, The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer, Hum. Reprod., 21, 583, 10.1093/humrep/del201 Baarends, 1995, Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth, Endocrinology, 136, 4951, 10.1210/en.136.11.4951 Bath, 2003, Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound, Hum. Reprod., 18, 2368, 10.1093/humrep/deg473 Bersinger, 2007, Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid, Clin. Chim. Acta., 384, 174, 10.1016/j.cca.2007.05.011 Bezard, 1987, Immunocytochemical study of anti-Mullerian hormone in sheep ovarian follicles during fetal and post-natal development, J. Reprod. Fertil., 80, 509, 10.1530/jrf.0.0800509 Broer, 2009, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count, Fertil. Steril., 91, 705, 10.1016/j.fertnstert.2007.12.013 Burger, 2007, A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project, Hum. Reprod. Update, 13, 559, 10.1093/humupd/dmm020 Cook, 2000, Serum mullerian-inhibiting substance levels during normal menstrual cycles, Fertil. Steril., 73, 859, 10.1016/S0015-0282(99)00639-1 de Vet, 2002, Antimullerian hormone serum levels: a putative marker for ovarian aging, Fertil. Steril., 77, 357, 10.1016/S0015-0282(01)02993-4 Faddy, 2000, Follicle dynamics during ovarian ageing, Mol. Cell. Endocrinol., 163, 43, 10.1016/S0303-7207(99)00238-5 Faddy, 1996, Ovary and ovulation: a model conforming the decline in follicle numbers to the age of menopause in women, Hum. Reprod., 11, 1484, 10.1093/oxfordjournals.humrep.a019422 Faddy, 1992, Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause, Hum. Reprod., 7, 1342, 10.1093/oxfordjournals.humrep.a137570 Fanchin, 2003, Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation, Hum. Reprod., 18, 328, 10.1093/humrep/deg043 Fanchin, 2003, Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3, Hum. Reprod., 18, 323, 10.1093/humrep/deg042 Fanchin, 2005, High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status, Hum. Reprod., 20, 923, 10.1093/humrep/deh688 Fauser, 2010, Mild ovarian stimulation for IVF: 10years later, Hum. Reprod., 25, 2678, 10.1093/humrep/deq247 Fleming, 2006, Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone, Hum. Reprod., 21, 1436, 10.1093/humrep/dei499 Freour, 2007, Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART), Clin. Chim. Acta, 375, 162, 10.1016/j.cca.2006.06.013 Giuseppe, 2007, Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD), Hematology, 12, 141, 10.1080/10245330600954072 Gleicher, 2010, Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve, Fertil. Steril., 94, 2824, 10.1016/j.fertnstert.2010.04.067 Groome, N.P., Cranfield, M., Themmen, A.P.N., Savjani, G.V., Mehta, K. 2006. (Eds.), Immunological assay and antibodies for anti-Mullerian hormone. United States Patent 7897350. Hagen, 2010, Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients, J. Clin. Endocrinol. Metab., 95, 5003, 10.1210/jc.2010-0930 Hansen, 2008, A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause, Hum. Reprod., 23, 699, 10.1093/humrep/dem408 Hansen, 2011, Correlation of ovarian reserve tests with histologically determined primordial follicle number, Fertil. Steril., 95, 170, 10.1016/j.fertnstert.2010.04.006 Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat. Med., 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 Hart, 2010, Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS), Fertil. Steril., 94, 1118, 10.1016/j.fertnstert.2009.11.002 Heijnen, 2007, A mild treatment strategy for in vitro fertilisation: a randomised non-inferiority trial, Lancet, 369, 743, 10.1016/S0140-6736(07)60360-2 Hickey, 2011, Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis, Hum. Reprod., 26, 1469, 10.1093/humrep/der102 Hudson, 1990, An immunoassay to detect human mullerian inhibiting substance in males and females during normal development, J. Clin. Endocrinol. Metab., 70, 16, 10.1210/jcem-70-1-16 Kelsey, 2011, A validated model of serum anti-müllerian hormone from conception to menopause, PLoS One., 6, e22024, 10.1371/journal.pone.0022024 Kevenaar, 2006, Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice, Endocrinology, 147, 3228, 10.1210/en.2005-1588 Kevenaar, 2008, A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients, J. Clin. Endocrinol. Metab., 93, 1310, 10.1210/jc.2007-2205 Kumar, 2010, Development of a second generation anti-Mullerian hormone (AMH) ELISA, J. Immunol. Methods, 362, 51, 10.1016/j.jim.2010.08.011 La Marca, 2004, Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation, Hum. Reprod., 19, 2738, 10.1093/humrep/deh508 La Marca, 2005, Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause, J. Soc. Gynecol. Investig., 12, 545, 10.1016/j.jsgi.2005.06.001 La Marca, 2006, Serum anti-mullerian hormone levels in women with secondary amenorrhea, Fertil. Steril., 85, 1547, 10.1016/j.fertnstert.2005.10.057 La Marca, 2006, Serum anti-Mullerian hormone throughout the human menstrual cycle, Hum. Reprod., 21, 3103, 10.1093/humrep/del291 La Marca, 2007, The anti-Mullerian hormone and ovarian cancer, Hum. Reprod. Update, 13, 265, 10.1093/humupd/dml060 La Marca, 2010, Normal serum concentrations of anti-Mullerian hormone in women with regular menstrual cycles, Reprod. Biomed. Online, 21, 463, 10.1016/j.rbmo.2010.05.009 La Marca, 2010, Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART), Hum. Reprod. Update, 16, 113, 10.1093/humupd/dmp036 La Marca, 2011, Anti-Mullerian Hormone (AMH) based prediction model for the live birth in assisted reproduction, Reprod. Biomed. Online, 22, 341, 10.1016/j.rbmo.2010.11.005 Laven, 2004, Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age, J. Clin. Endocrinol. Metab., 89, 318, 10.1210/jc.2003-030932 Lee, 1993, Mullerian inhibiting substance. a gonadal hormone with multiple functions, Endocr. Rev., 14, 152 Lee, 1996, Mullerian inhibiting substance in humans: normal levels from infancy to adulthood, J. Clin. Endocrinol. Metab., 81, 571, 10.1210/jc.81.2.571 Lee, 2011, Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits, Fertil. Steril., 95, 2602, 10.1016/j.fertnstert.2011.01.126 Leushuis, 2009, Prediction models in reproductive medicine: a critical appraisal, Hum. Reprod. Update, 15, 537, 10.1093/humupd/dmp013 Li, 2010, Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination, Fertil. Steril., 94, 2177, 10.1016/j.fertnstert.2009.12.059 Lie Fong, 2008, Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies, Hum. Reprod., 23, 674, 10.1093/humrep/dem392 Long, 2000, Detection of minimal levels of serum anti-mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay, J. Clin. Endocrinol. Metab., 85, 540, 10.1210/jc.85.2.540 Lutchman Singh, 2007, Predictors of ovarian reserve in young women with breast cancer, Br. J. Cancer, 96, 1808, 10.1038/sj.bjc.6603814 MacLaughlin, 1992, Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain, Endocrinology, 131, 291, 10.1210/en.131.1.291 Mathur, 2007, Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome, Hum. Fertil. (Camb), 10, 75, 10.1080/14647270601111239 McGee, 2000, Initial and cyclic recruitment of ovarian follicles, Endocr. Rev., 21, 200, 10.1210/er.21.2.200 Mulders, 2004, Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility, Hum. Reprod., 19, 2036, 10.1093/humrep/deh373 Nardo, 2007, Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history, Gynecol. Endocrinol., 23, 486, 10.1080/09513590701532815 Nelson, 2011, Predicting live birth, preterm and low birth weight infant after in-vitro fertilisation: a prospective study of 144,018 treatment cycles, PLoS Med., 8, e1000386, 10.1371/journal.pmed.1000386 Nelson, 2007, Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy, Hum. Reprod., 22, 2414, 10.1093/humrep/dem204 Nelson, 2009, Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception, Hum. Reprod., 24, 867, 10.1093/humrep/den480 Nelson, 2011, External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients, Reprod. Biomed. Online., 10.1016/j.rbmo.2011.05.006 Nelson, 2011, Nomogram for the decline in serum antimullerian hormone: a population study of 9601 infertility patients, Fertil. Steril., 95, 736, 10.1016/j.fertnstert.2010.08.022 Pellatt, 2006, Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries, J. Clin. Endocrinol. Metab., 2006, 1582 Pigny, 2003, Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest, J. Clin. Endocrinol. Metab., 88, 5957, 10.1210/jc.2003-030727 Pigny, 2006, Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 91, 941, 10.1210/jc.2005-2076 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum. Reprod., 19, 41, 10.1093/humrep/deh098 Seifer, 2002, Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles, Fertil. Steril., 77, 468, 10.1016/S0015-0282(01)03201-0 Soto, 2009, Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus, Hum. Reprod., 24, 2838, 10.1093/humrep/dep276 Sowers, 2008, Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition, J. Clin. Endocrinol. Metab., 93, 3478, 10.1210/jc.2008-0567 Sowers, 2010, Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles, Fertil. Steril., 94, 1482, 10.1016/j.fertnstert.2009.07.1674 Streuli, 2009, Clinical uses of anti-Müllerian hormone assays: pitfalls and promises, Fertil. Steril., 91, 226, 10.1016/j.fertnstert.2007.10.067 Taieb, 2008, Two immunoassays for antimullerian hormone measurement: analytical and clinical performances, Ann. Biol. Clin. (Paris), 66, 537 Tehrani, 2009, A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause, Menopause, 16, 797, 10.1097/GME.0b013e318193e95d van Beek, 2007, Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin’s lymphoma during childhood, J. Clin. Endocrinol. Metab., 92, 3869, 10.1210/jc.2006-2374 van Disseldorp, 2008, Relationship of serum antimullerian hormone concentration to age at menopause, J. Clin. Endocrinol. Metab., 93, 2129, 10.1210/jc.2007-2093 van Disseldorp, J., Lambalk, C.B., Kwee, J., Looman, C.W., Eijkemans, M.J., Fauser, B.C., and Broekmans, F.J. 2009. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum. Reprod. van Rooij, 2002, Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve, Hum. Reprod., 17, 3065, 10.1093/humrep/17.12.3065 van Rooij, 2004, Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition, Menopause, 11, 601, 10.1097/01.GME.0000123642.76105.6E van Rooij, 2005, Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study, Fertil. Steril., 83, 979, 10.1016/j.fertnstert.2004.11.029 Visser, 2005, Anti-Mullerian hormone and folliculogenesis, Mol. Cell. Endocrinol., 234, 81, 10.1016/j.mce.2004.09.008 Wallace, 2010, Human ovarian reserve from conception to the menopause, PLoS One, 5, e8772, 10.1371/journal.pone.0008772 Wallace, 2011, A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II), Ann. Clin. Biochem., 48, 70, 10.1258/acb.2011.010172 Weenen, 2004, Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment, Mol. Hum. Reprod., 10, 77, 10.1093/molehr/gah015 Wunder, 2008, Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women, Fertil. Steril., 89, 927, 10.1016/j.fertnstert.2007.04.054